Boule Diagnostics Logo

Boule Diagnostics

ISIN

SE0011231158

Ticker

BOUL

Sector

Health Care

Sub-Industry

Health Care Equipment

Country

Sweden

Year Founded

About Boule Diagnostics

Company Description

Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary diagnostics.

Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets.

Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011.

Served Area

Worldwide

Headquarters

Domnarvsgatan 4
16353, Spånga
Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 479,710,000.00 572,030,000.00 759,964,000.00
Noncurrent Assets N/A 283,091,000.00 329,655,000.00 421,550,000.00
Property Plant And Equipment N/A 54,745,000.00 47,426,000.00 58,574,000.00
Machinery N/A 4,682,000.00 6,137,000.00 7,372,000.00
Other Property Plant And Equipment N/A 10,985,000.00 11,230,000.00 12,350,000.00
Goodwill N/A 72,906,000.00 78,693,000.00 88,123,000.00
Intangible Assets Other Than Goodwill N/A 115,625,000.00 162,885,000.00 225,235,000.00
Noncurrent Trade Receivables N/A 36,816,000.00 36,822,000.00 45,796,000.00
Other Noncurrent Financial Assets N/A 2,998,000.00 3,828,000.00 3,823,000.00
Other Noncurrent Assets N/A 4,192,000.00 3,211,000.00 2,116,000.00
Current Assets N/A 196,619,000.00 242,375,000.00 338,414,000.00
Inventories N/A 54,542,000.00 59,038,000.00 75,265,000.00
Current Raw Materials And Current Production Supplies N/A 35,803,000.00 30,431,000.00 31,372,000.00
Work In Progress N/A 3,932,000.00 4,458,000.00 6,697,000.00
Finished Goods N/A 14,807,000.00 24,149,000.00 37,196,000.00
Trade And Other Current Receivables N/A 109,088,000.00 145,155,000.00 166,245,000.00
Current Prepaid Expenses N/A 8,897,000.00 5,508,000.00 N/A
Other Current Receivables N/A 3,517,000.00 7,764,000.00 4,869,000.00
Current Tax Assets Current N/A 3,040,000.00 3,999,000.00 7,195,000.00
Cash and cash equivalents 21,580,000.00 32,989,000.00 38,183,000.00 96,904,000.00
Equity And Liabilities N/A 479,710,000.00 572,030,000.00 759,964,000.00
Equity 332,870,000.00 269,305,000.00 295,735,000.00 462,504,000.00
Issued Capital N/A 4,854,000.00 4,854,000.00 9,708,000.00
Retained Earnings N/A 58,914,000.00 71,507,000.00 73,556,000.00
Additional Paidin Capital N/A 202,403,000.00 202,386,000.00 336,763,000.00
Equity Attributable To Owners Of Parent N/A 269,305,000.00 295,735,000.00 462,504,000.00
Liabilities N/A 210,405,000.00 276,295,000.00 297,459,000.00
Noncurrent Liabilities N/A 57,672,000.00 65,094,000.00 96,426,000.00
Deferred Tax Liabilities N/A 12,754,000.00 10,504,000.00 8,394,000.00
Current Liabilities N/A 152,733,000.00 211,202,000.00 201,034,000.00
Trade And Other Current Payables To Trade Suppliers N/A 29,352,000.00 41,165,000.00 33,321,000.00
Current Accruals And Current Deferred Income Including Current Contract Liabilities N/A N/A 36,357,000.00 37,084,000.00
Other Current Payables N/A 6,473,000.00 20,764,000.00 16,426,000.00
Current Tax Liabilities Current N/A 3,304,000.00 6,662,000.00 7,635,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 400,458,000.00 463,344,000.00 548,087,000.00
Profit Loss From Operating Activities -5,928,000.00 36,018,000.00 28,970,000.00
Gains Losses On Net Monetary Position N/A -3,109,000.00 5,000.00
Finance Income 1,522,000.00 1,352,000.00 1,778,000.00
Finance Costs 4,338,000.00 5,493,000.00 9,904,000.00
Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates -40,278,000.00 N/A N/A
Profit Loss Before Tax -49,021,000.00 28,768,000.00 20,849,000.00
Income Tax Expense Continuing Operations -1,056,000.00 5,496,000.00 8,121,000.00
Profit (loss) -47,966,000.00 23,272,000.00 12,728,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -47,966,000.00 23,272,000.00 12,728,000.00
Adjustments For Reconcile Profit Loss N/A 52,914,000.00 19,451,000.00 23,067,000.00
Adjustments For Decrease Increase In Inventories N/A -1,405,000.00 -3,046,000.00 -9,779,000.00
Adjustments For Reconcile Profit Loss N/A 52,914,000.00 19,451,000.00 23,067,000.00
Cash Flows From Used In Operations N/A 38,494,000.00 46,658,000.00 28,760,000.00
Interest Paid Classified As Operating Activities N/A 4,338,000.00 5,493,000.00 9,851,000.00
Interest Received Classified As Operating Activities N/A 436,000.00 1,352,000.00 1,778,000.00
Cash Flows From Used In Operating Activities N/A 75,239,000.00 43,284,000.00 -11,353,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 4,585,000.00 3,149,000.00 6,433,000.00
Cash Flows From Used In Investing Activities N/A -46,006,000.00 -56,370,000.00 -74,961,000.00
Proceeds From Issuing Shares N/A N/A N/A 149,507,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 11,024,000.00 19,052,000.00 24,031,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 11,138,000.00 11,766,000.00 13,708,000.00
Cash Flows From Used In Financing Activities N/A -14,881,000.00 15,754,000.00 140,550,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 14,351,000.00 2,669,000.00 54,236,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -2,942,000.00 2,525,000.00 4,486,000.00
Cash and cash equivalents 21,580,000.00 32,989,000.00 38,183,000.00 96,904,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q4 Swedish 🇸🇪 Published: 09.05.2023
  • Consolidated Report 2021 - Q4 Swedish 🇸🇪

Insider Trades

Date Trading entity / Person Association Trade type Volume
15.05.2023 Torben Jörgensen Other Buy SEK 54,000.00
03.05.2023 Torben Jörgensen Other Buy SEK 120,000.00
03.04.2023 Torben Jörgensen Other Buy SEK 60,000.00
27.02.2023 Jan Benjaminson Other Buy SEK 102,000.00
03.02.2023 Yvonne Mårtensson Other Buy SEK 100,224.45
16.12.2022 Jesper Söderqvist Other Buy SEK 34,680.10
15.12.2022 Jesper Söderqvist Other Buy SEK 706,086.22
14.12.2022 Jesper Söderqvist Other Buy SEK 223,533.84
21.11.2022 Emil Hjalmarsson Other Buy SEK 105,200.00
29.12.2021 Jan Mattias Isaksson Other Buy SEK 12,200.00

Capital Markets Information

ISIN

SE0011231158

LEI

213800IK1TGY858TKZ45

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.